Expression analysis of miR-125a-3p and miR-125a-5p in patients with myeloproliferative neoplasm
Author(s):
Abstract:
Background And Objectives
Deregulation of microRNA (miRNA) expression can lead to cancer initiation and progression. The aim of this study was to investigate miR-125a expression level in patients with myeloproliferative neoplasm and its correlation with JAK2 allele burden and laboratory findings.Materials And Methods
This is an experimental study. In total, 20 patients with Polycythemia Vera (PV) and 20 patients with essential thrombocythemia(ET) were examined. Ten healthy subjects were checked as controls. We performed JAK2 V617F allele burdens measurement by quantitative real-time polymerase chain reaction. Expression analysis of miR‑125a-3p and miR-125a-5p was performed by Real-time RT-PCR. Results were analyzed by SPSS 16 software and MannWhitney test and Spearmans correlation was applied for analysis.Results
miR-125a-5p was up regulated in both PV (p = 0.003) and ET patients (p = 0.002). In PV group, a significant correlation was observed between miR-125a-5p and platelet counts (p = 0.01, r = 0.531). The median allele burden of the JAK2 V617F was 66% (62.37 ± 18.29) for patients with PV and 40% (43.4 ± 13.95) for patients with ET (p = 0.007).Conclusions
In conclusion, our data indicate that there is the aberrant expression of miRNAs such as miR-125a in MPNs patients except JAK2 mutation.Language:
Persian
Published:
Scientific Journal of Iranian Blood Transfusion Organization, Volume:13 Issue: 3, 2016
Pages:
215 to 223
https://magiran.com/p1580341
سامانه نویسندگان
مقالات دیگری از این نویسنده (گان)
-
Prognostic Significance of Circulating and Disseminated Tumor Cells in Breast Cancer Patients before and after Adjuvant Chemotherapy
Parisa Ghaffari, Meysam Yousefi, Mozaffar Aznab, Negar Khazan, Marjan Yaghmaie, Davood Bashash, Mohammad Vaezi, Ardashir Ghavamzadeh, Seyed H Ghaffari *
Cell Journal (Yakhteh), May 2024 -
The evaluation of TLR1, TLR2, TLR4, TLR7, and TLR8 expression levels in the newly-diagnosed acute myeloid leukemia (AML) patients
Kosar Fateh, Bahareh Kashani, Zahra Hasanpour, Naser Shagerdi Esmaeli, Vahid Amiri, Seyed H. Ghaffari, Davood Bashash*
Iranian Journal of Blood and Cancer, Dec 2022